期刊文献+

食管鳞癌组织LSD1表达与预后相关性分析 被引量:9

Correlation between LSD1expression and prognosis in patients with esophageal squamous cell carcinoma
原文传递
导出
摘要 目的:研究组蛋白赖氨酸特异性脱甲基酶1(lysine specific demethylase 1,LSD1)在食管鳞癌组织中的表达及其与临床病理因素的关系,并探讨其与预后的相关性。方法:收集2005-01-01-2006-12-31在福建省肿瘤医院胸外科接受食管癌三野根治术且术前未接受放疗或化疗的食管鳞癌患者135例。免疫组化检测135例食管鳞癌及其配对癌旁正常食管黏膜组织的LSD1表达水平。运用χ2检验分析肿瘤组织LSD1表达与临床病理因素的关系。运用Kaplan-Meier方法和Log-rank检验分析肿瘤组织LSD1表达与患者术后总生存时间的关系。采用Cox模型对食管癌患者预后相关因素进行多因素回归分析。结果:食管鳞癌组织LSD1强阳性表达率为53.3%,在正常食管黏膜组织中为7.6%,差异有统计学意义,χ2=9.016,P=0.002。LSD1高表达与性别(χ2=0.396,P=0.546)、年龄(χ2=2.530,P=0.123)、T分期(χ2=1.264,P=0.286)、淋巴结转移(χ2=1.136,P=0.343)、TNM分期(χ2=0.396,P=0.546)和分化(χ2=0.415,P=0.537)无显著相关性,而与生存时间是否超过5年(χ2=6.699,P=0.013)显著相关。Cox多因素回归分析显示,淋巴结转移(P=0.001)、肿瘤浸润深度(P=0.004)和LSD1表达水平(P=0.020)是食管鳞癌患者的独立预后因素。生存分析提示,LSD1强阳性组患者预后明显差于LSD1弱阳性组患者,P=0.008。亚组分析显示,在有淋巴结转移的患者中,肿瘤LSD1强阳性与患者预后相关,P=0.014;而在无淋巴结转移的患者中,LSD1强阳性与预后无显著相关性,P=0.373。结论:LSD1在食管鳞癌组织中表达上调,其强阳性表达与不良预后相关。 OBJECTIVE: To investigate the expression of LSD1 in esophageal squamous cell carcinoma (ESCC) and relationship of LSD1 and clinicopathological factors of ECSS patients. METHODS: The data from 135 patients with tho racic esophageal squamous cell carcinoma who underwent curative R0 esophagectomy with three-field lymph node dissec tion from January lst,2005 to December 31st, 2006 in Fujian Cancer Hospital were retrospectively examined. The LSD1 expression in tumors and adjacent normal epithelia from 135 ESCC patients was detected by immunohistochemical stai ning. Correlations of LSD1 expression and clinicopathological factors were analyzed using C-squared test. Survival curves were generated according to the Kaplan-Meier method,and the statistical analysis was performed by Log-rank test. Multi- variate analysis were also performed to assess the element which affect the survival of patients by Cox regression. RE- SULTS: The expression of LSD1 protein was significantly up-regulated in tumors with 53.3% strong positive staining, compared with paired adjacent normal epithelia with 7.6% strong positive staining (P=0. 002). No correlation was found between expression of LSD1 in tumor cells and clinicopathologic factors such as gender (X2 = 0. 396, P = 0. 546), age (?(2 =2. 530,P=0. 123) ,tumor invasion (c2 =1. 264,P=0. 286) ,lymph node metastasis (3(2 = 1. 136,P=0. 343),TNM stage (X2 = 0. 396, P = 0. 546) and tumor differentiation (3(2 = 0. 415, P = 0. 537). Strong positive staining of LSD1 in tumor cell was correlated with 5-year survival rate (x2 = 6. 699, P 0. 013). Cox-proportional multivariate analysis showed that expression of LSD1 was a significant prognostic factor in overall survival(P= 0. 020). The survival curves calculated by Kaplan-Meier method further showed that the patients with strong LSD1 expression had a shorter survival than patients
出处 《中华肿瘤防治杂志》 CAS 北大核心 2014年第4期280-283,288,共5页 Chinese Journal of Cancer Prevention and Treatment
关键词 食管肿瘤 组蛋白赖氨酸特异性脱甲基酶1 预后 免疫组织化学 esophageal neoplasms lysine specific demethylase 1 prognosis immunohistrochemistry
  • 相关文献

参考文献19

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin,2011,61(2) :69-90. 被引量:1
  • 2赫捷,邵康.中国食管癌流行病学现状、诊疗现状及未来对策[J].中国癌症杂志,2011,21(7):501-504. 被引量:454
  • 3Shi Y,Lan F, Matson C, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 [J]. Cell, 2004.119(7):941-953. 被引量:1
  • 4Wang J ,Scully K, Zhu X, et al. Opposing LSD1 complexes func- tion in developmental gene activation and repression programmes [J]. Nature,2007,446(7138) :882-887. 被引量:1
  • 5Hayami S,Kelly JD,Cho HS,et al. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various canc- ers[J]. Int J Cancer,2011,128(3) : 574-586. 被引量:1
  • 6LV T, Yuan D, Miao X, et al. Over-expression of LSD1 promotes proliferation,migration and invasion in non-small cell lung cancer [J]. PLoS One,2012,7(4):e35065. 被引量:1
  • 7Schenk T,Chen WC,Gollner S,et al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation path- way in acute myeloid leukemia[J]. Nat Med,2012,18(4):605-611. 被引量:1
  • 8秦豫培,王立东,常志伟,郭涛,李吉林,宋昕.食管癌组织与外周血RASSF1A甲基化的检测及其临床意义[J].中华肿瘤防治杂志,2009,16(5):359-361. 被引量:9
  • 9Metzger E, Wissmann M, Yin N, et al. LSD1 demethylates re pressive histone marks to promote androgen-receptor-dependent transeription[J]. Nature, 2005,437 (7057) : 436-439. 被引量:1
  • 10Huang J,Sengupta R,Espejo AB, et al. p53 is regulated by the lysine demethylase LSD1[J]. Nature,2007,449(7158) :105-108. 被引量:1

二级参考文献53

共引文献518

同被引文献53

  • 1孔灵玲,张国安,崔文,王旭,周建,侯森,张仁亚.甲状腺癌组织LSD1表达临床意义分析[J].中华肿瘤防治杂志,2013,20(2):118-120. 被引量:4
  • 2Li S ,Wu J, Chert Y,et al. ERCC1 expression levels predict the outcome of platinum-based chemotherapies in advanced bladder cancer: a meta-analysis [ J ]. Anticancer Drugs, 2014,25 ( 10 ) : 106 - 114. 被引量:1
  • 3FERLAY J,SOERJOMATARAM I,DIKSHIT R,et al.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):359-386. 被引量:1
  • 4LV T,YUAN D,MIAO X,et al.Over-expression of LSD1 promotes proliferation,migration and invasion in non-small cell lung cancer[J].PLo S One,2012,7(4):35065. 被引量:1
  • 5GOLDHIRSCH A,WINER E P,COATES A S,et al.Personalizing the treatment of women with early breast cancer:highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013[J].Ann Oncol,2013,24(9):2206-2223. 被引量:1
  • 6SHI Y,LAN F,MATSON C,et al.Histone demethylation mediated by the nuclear amine oxidase homolog LSD1[J].Cell,2004,119(7):941-953. 被引量:1
  • 7YANG M,GOEKE C B,LUO X,et al.Structural basis for Co REST-dependent demethylation of nueleosomes by the human LSD1 histone demethylase[J].Mol Cell,2006,23(3):377-387. 被引量:1
  • 8O'SHAUGHNESSY J,SCHWARTZBERG L,DANSOMA,et al.Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer[J].J Clin Oncol,2014,32(34):3840-3847. 被引量:1
  • 9BASELGA J,GóMEZ P,GREIL R,et al.Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triplenegative breast cancer[J].J Clin Oncol,2013,31(20):2586-2592. 被引量:1
  • 10SCOUMANNE A,CHEN X.The lysine-specific demethylase 1 is required for cell proliferation in both p53-dependent and-independent manners[J].J Biol Chem,2007,282(21):15471-15475. 被引量:1

引证文献9

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部